ABT Today - Jul 24: Medtech Stocks Rebound
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
ABT Today - Jul 24: Medtech Stocks Rebound
-
Narrated by:
-
By:
So, what went down? The stock got a nice bump, which is a refreshing change in the medtech space. It seems like after a rough patch for a lot of medtech stocks, Abbott’s finally catching a break. People are starting to see it as a bargain. Yeah, that one stung for those who sold off.
Now, why the boost? Well, a few articles are buzzing about how Abbott’s earnings brought in some fresh attention. Investors are realizing that it might still be undervalued compared to peers like Boston Scientific and ResMed, which, let’s be real, aren’t exactly killing it either. There’s also chatter about Abbott possibly being a solid option for retirement income given its dividend profile. So, a mix of hopeful vibes and some stock comparisons got folks interested again.
One quick thing on the horizon? There’s ongoing talk about Abbott’s potential to keep growing, especially as the medtech market starts to shift. It’s definitely something to keep in mind as the industry evolves.
Wrapping it up, it’s nice to see Abbott making some moves today. Just remember, this is all for fun and info, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
No reviews yet